ZIMLAB NSE filing

Zim Laboratories Limited Files SEBI Regulation 74(5) Certificate for Q4 FY26

The RealCase readLow impact Neutral

Zim Laboratories Limited has filed a certificate under SEBI Regulation 74(5) for the quarter ended March 31, 2026. The company's RTA, MUFG Intime India Private Limited, confirmed the processing of dematerialized securities and cancellation of physical certificates.

Why it matters

This is a standard regulatory filing and does not introduce new material information that would affect the company's business or financial standing.

The market read

The announcement is a routine compliance filing and does not contain any information that would significantly impact the company's stock price or operations.

Zim Laboratories Limited has submitted a certificate confirming compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. The certificate was issued by MUFG Intime India Private Limited, the company's Registrar and Transfer Agent (RTA).

The RTA confirmed that securities received from depository participants for dematerialization during the quarter ended March 31, 2026, were processed and confirmed to the depositories. Furthermore, the security certificates received for dematerialization were mutilated and canceled after verification, with the depositories' names substituted in the register of members within the prescribed timelines.

This compliance filing pertains to the period ending March 31, 2026, and has been submitted to both the BSE Limited and the National Stock Exchange of India Limited for their information and records.

Filing to action

What to do with a filing like this

Zim Laboratories Limited filed this with the NSE as a statutory disclosure, categorised under sebi compliance filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Zim Laboratories Limited. Read the original for the full detail.

View original filing